 The COVID-19 Vaccine & the New Era of Manufacturing Manufacturers have been operating at an expedited production schedule for the past year to produce medical products, PPE, goods used daily for home use, and several approved vaccines. What are the lessons learned in the past year while operating on constant escalated timelines? How are biopharmaceutical manufacturers prioritizing vaccines and continuing to produce other medicines at the same time? And what can traditional manufacturing competitors stepping in to fulfill vaccine production quotas teach us about cooperation in the name of common good? The Hill's Steve Clemons and Julia Manchester will sit down with government leaders, manufacturing and vaccine production experts to discuss how the manufacturing community and their related industries will use what they learned in 2020 to tackle the public health emergencies of the future. Speakers: Dr. Simone Blayer, Global Head of Chemistry, Manufacturing & Control, Center for Vaccine Innovation and Access, PATH Rep. Bill Foster (D-IL), Co-Sponsor, American Manufacturing Leadership Act Karyne Jones, President & CEO, The National Caucus & Center on Black Aging, Inc. Rep. Dan Kildee (D-MI), Chief Deputy Whip; Member, Ways & Means Committee Sean Kirk, EVP, Manufacturing & Technical Operations, Emergent BioSolutions Frank Luntz, Pollster, FIL, Inc. Cody Powers, Principal, ZS Associates Dr. José R. Romero, MD, FAAP, Chair, Advisory Committee on Immunization Practices Committee, CDC; Secretary, Dept. of Health, Arkansas Rep. Haley Stevens (D-MI), Co-Sponsor, American Manufacturing Leadership Act Rep. Jackie Walorski (R-IN), Member, Ways & Means Committee; Member, Manufacturing Caucus Rep. Brad Wenstrup, D.P.M (R-OH), Member, Ways & Means Committee; Member, GOP Doctors Caucus Watch Today!
1:00 PM ET/10:00 AM PT
Thursday, March 25 Questions for our speakers? Join the conversation using @TheHillEvents and #TheHillVaccine. | 
No comments:
Post a Comment